Heart failure recovery: time to cut the pills?
NCT ID NCT06724653
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at heart failure patients whose heart function has improved to normal levels. It tests whether gradually stopping one of their heart medications (RAS blocker or beta blocker) is safe, compared to staying on all medications. The goal is to see if patients can maintain their recovery without relapse. 150 adults are being recruited.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
RAS blocker and beta blocker
What this could lead to
If successful, this could show that some heart failure patients with recovered heart function can safely take fewer medications without their condition worsening.
What could go wrong
This is a small, early-phase trial (150 people) and not yet proven. Tapering medication may cause heart function to decline again in some patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chungnam national university hospital
RECRUITINGDaejeon, Republic of Korea, 35015, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Jeonbuk national university hospital
RECRUITINGJeonju, Jeollabuk-do, 54907, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••